National Health Commission

Airdoc Technology (02251.HK) achieved remarkable success in 2023, accelerating its commercialization in an unparalleled way  

Retrieved on: 
Wednesday, April 10, 2024

In 2023, Airdoc Technology significantly accelerated its commercialization,while most of its peers were still in the experimental stage or early stages of commercialization.

Key Points: 
  • In 2023, Airdoc Technology significantly accelerated its commercialization,while most of its peers were still in the experimental stage or early stages of commercialization.
  • 2) health risk assessment solutions, covering 55 types of lesions, providing chronic disease management and health assessments for healthcare industry.
  • Airdoc Technology practices the use of AI technology to assist in the prevention and control of myopia among teenagers and the development of eye health.
  • In July 2023, Airdoc Technology participated in the formulation of the "Expert Consensus on Assessing the Risk of Cardiovascular Diseases Using Artificial Intelligence Technology Based on Fundus Images."

China's Gathering Place for Innovative Medical Products: VBEF's 8th Future Healthcare Ecological Fair Will Be Held in Beijing Soon

Retrieved on: 
Wednesday, March 20, 2024

It will be held at the Beijing Beiren Yichuang International Convention and Exhibition Center from May 7th to 10th, 2024.

Key Points: 
  • It will be held at the Beijing Beiren Yichuang International Convention and Exhibition Center from May 7th to 10th, 2024.
  • The results interpret future trends to global medical innovators, demonstrate the linkage and cooperation between China's medical innovation technology and industry to the world, provide medical innovative products and solutions to the world, and demonstrate the true power of medical innovation.
  • In 2024, Vcbeat will upgrade the Future Medical Top 100 Conference held for seven consecutive years to the VBEF Future Healthcare Ecological Fair to help China's medical innovation industry accelerate the growth and promote a new medical innovation ecosystem.
  • Global medical industry practitioners are welcome to participate in the 8th VBEF Future Healthcare Ecological Fair in 2024.

Crown Bioscience Recognized Once Again as T+ Employer® for the Third Year in a Row

Retrieved on: 
Tuesday, March 19, 2024

The T+ Employer® certification celebrates Crown Bioscience's impactful values and trendsetting role within the pharmaceutical, medical, life science, and virtual healthcare industries.

Key Points: 
  • The T+ Employer® certification celebrates Crown Bioscience's impactful values and trendsetting role within the pharmaceutical, medical, life science, and virtual healthcare industries.
  • Company-wide initiatives such as significant contributions to oncology research and promoting cross-regional departmental collaboration via digitization and human systems have distinguished Crown Bioscience as a paradigm of employer excellence.
  • This achievement underscores Crown Bioscience’s dedication to setting high standards and pushing the boundaries of innovation across all facets of its business.
  • It reflects the company's strong resolve to enrich the work environment, consistently deliver beyond client expectations, and elevate industry standards.

Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry

Retrieved on: 
Monday, March 11, 2024

SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place from April 11th to 14th in Shanghai.

Key Points: 
  • SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place from April 11th to 14th in Shanghai.
  • Attendees will be able to explore over 10,000 innovative products, highlighting the latest technological advancements in the medical equipment industry.
  • The exhibition, spanning more than 320,000 square meters, will showcase cutting-edge technological innovations across the entire healthcare industry chain.
  • Don't miss out on the chance to connect with industry leaders, explore the latest medical advancements, and expand your network.

Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry

Retrieved on: 
Monday, March 11, 2024

SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place from April 11th to 14th in Shanghai.

Key Points: 
  • SHANGHAI, March 11, 2024 /PRNewswire/ -- The 89th China International Medical Equipment Fair (CMEF) is scheduled to take place from April 11th to 14th in Shanghai.
  • Attendees will be able to explore over 10,000 innovative products, highlighting the latest technological advancements in the medical equipment industry.
  • The exhibition, spanning more than 320,000 square meters, will showcase cutting-edge technological innovations across the entire healthcare industry chain.
  • Don't miss out on the chance to connect with industry leaders, explore the latest medical advancements, and expand your network.

China's Gov't departments handle 12,480 suggestions, proposals last year

Retrieved on: 
Tuesday, March 5, 2024

In particular, the departments handled 7,955 suggestions, accounting for 95.7 percent of all suggestions submitted, and 4,525 proposals, 96.5 percent of all proposals submitted, said the spokesperson Xing Huina.

Key Points: 
  • In particular, the departments handled 7,955 suggestions, accounting for 95.7 percent of all suggestions submitted, and 4,525 proposals, 96.5 percent of all proposals submitted, said the spokesperson Xing Huina.
  • Xing said that the departments rolled out over 2,000 policy measures based on some 4,700 suggestions and proposals last year.
  • China's Ministry of Human Resources and Social Security handled 962 suggestions and proposals last year.
  • The National Health Commission has made significant progress in handling related matters by fully absorbing and adopting the suggestions and proposals.

Enhancing Leadership in Gynecology, Asieris Pharmaceuticals Appoints Sophia Cao to Lead the Newly-Established Women's Health Business Unit, Accelerating Strategic Expansion

Retrieved on: 
Tuesday, January 9, 2024

This strategic move is designed to enhance the company's focus on genitourinary diseases and strengthen its position in women's health.

Key Points: 
  • This strategic move is designed to enhance the company's focus on genitourinary diseases and strengthen its position in women's health.
  • Asieris Pharmaceuticals will leverage both in-house discoveries and external partnerships to enrich its gynecological portfolio, thereby reinforcing its leadership in women's health.
  • In November 2020, the World Health Organization (WHO) released a Global Strategy to Accelerate the Elimination of Cervical Cancer.
  • To further deliver its strategic vision and commitment in the realm of women's health, Asieris Pharmaceuticals has announced the establishment of the Women's Health Business Unit.

Global Times: Senior vloggers embrace vibrant twilight years in fashionable ways, showcase a more dignified old age with stronger security

Retrieved on: 
Friday, December 29, 2023

The average age of the 13 vloggers was 77 years old, and Wu was among them.

Key Points: 
  • The average age of the 13 vloggers was 77 years old, and Wu was among them.
  • They use trendy language, short videos and live broadcasts to share scientific and humanistic knowledge that young people are interested in.
  • Living in a society of accelerated population aging, how can we ensure that the elderly have support, happiness, and security in their old age?
  • How can institutionalized guarantees bring about a more dignified later life and enable them to embrace more possibilities?

New Illuma Growing-up Infant Formula Now Available throughout China

Retrieved on: 
Thursday, December 21, 2023

The industry responded favorably to the illuma HMO growing-up infant formula as soon as it was made available.

Key Points: 
  • The industry responded favorably to the illuma HMO growing-up infant formula as soon as it was made available.
  • The illuma HMO Growing-Up Infant Formula is intended as a substantially improved nutritional option for preschoolers above 3 years old.
  • With the addition of six crucial HMOs, the company's most recent infant formula product, illuma LUXA, has the highest number of HMOs of any infant formula on the market right now.
  • The introduction of the illuma HMO growing-up infant formula highlights Wyeth Nutrition's "in China, for China" commitment in addition to showcasing the company's overall strength.

New Illuma HMO Growing-up Infant Formula Now Available throughout China

Retrieved on: 
Thursday, December 21, 2023

SHANGHAI, Dec. 21, 2023 /PRNewswire/ -- Wyeth Nutrition announced that its first illuma HMO growing-up infant formula added with two human milk oligosaccharides (HMOs) is now available throughout China, which makes Wyeth Nutrition the first multinational company that sells the HMO infant formula in the market just two months after two HMOs were newly authorized as food additives by China's National Health Commission (NHC). Prior to that, the company is also the first foreign company that manufactured HMO infant formula in China, just one month after NHC's approval, at the company's GMP-level factory in Suzhou. Now, Chinese consumers can order the first HMO infant formula added with two HMOs in China via various channels, including the illuma flagship store on Tmall, the Wyeth flagship store on JD.COM, and numerous offline stores across the country.

Key Points: 
  • Prior to that, the company is also the first foreign company that manufactured HMO infant formula in China, just one month after NHC's approval, at the company's GMP-level factory in Suzhou.
  • It took the lead to launch the first illuma HMO growing-up infant formula in November.
  • After the Chinese Government approved the two HMOs, Wyeth illuma reacted quickly by launching the first HMO growing-up infant formula.
  • In 2017, Wyeth Nutrition launched the first illuma HMO product in Hong Kong, to cause quite a stir for HMO formulas.